NO20024325L - Rensede hepatitt C-viruskappeproteiner for diagnose og terapeutisk anvendelse - Google Patents

Rensede hepatitt C-viruskappeproteiner for diagnose og terapeutisk anvendelse

Info

Publication number: NO20024325L
Authority: NO; Norway
Prior art keywords: diagnosis; therapeutic use; envelope proteins; virus envelope; purified hepatitis
Prior art date: 2001-01-11

Application number

NO20024325A

Other languages

English (en)

Norwegian (no)

Other versions

NO20024325D0 (no

Inventor

Geert Maertens

Fons Bosman

Marie-Ange Buyse

Original Assignee

Innogenetics Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-11

Filing date

2002-09-10

Publication date

2002-11-11

2002-09-10 Application filed by Innogenetics Nv filed Critical Innogenetics Nv

2002-09-10 Publication of NO20024325D0 publication Critical patent/NO20024325D0/no

2002-11-11 Publication of NO20024325L publication Critical patent/NO20024325L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20024325A 2001-01-11 2002-09-10 Rensede hepatitt C-viruskappeproteiner for diagnose og terapeutisk anvendelse NO20024325L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US26066901P	2001-01-11	2001-01-11
US31576801P	2001-08-30	2001-08-30
PCT/EP2002/000219 WO2002055548A2 (en)	2001-01-11	2002-01-11	Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use

Publications (2)

Publication Number	Publication Date
NO20024325D0 NO20024325D0 (no)	2002-09-10
NO20024325L true NO20024325L (no)	2002-11-11

Family

ID=26948130

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20024325A NO20024325L (no)	2001-01-11	2002-09-10	Rensede hepatitt C-viruskappeproteiner for diagnose og terapeutisk anvendelse

Country Status (16)

Country	Link
EP (1)	EP1463753A2 (pt)
KR (1)	KR20020089371A (pt)
CN (1)	CN1547588A (pt)
AR (1)	AR032240A1 (pt)
AU (1)	AU2002238502B2 (pt)
BR (1)	BR0203518A (pt)
CA (1)	CA2400643A1 (pt)
CZ (1)	CZ20032164A3 (pt)
HU (1)	HUP0302416A2 (pt)
IL (1)	IL151033A0 (pt)
MX (1)	MXPA02008886A (pt)
NO (1)	NO20024325L (pt)
PL (1)	PL363175A1 (pt)
RU (1)	RU2313363C2 (pt)
TR (1)	TR200202169T1 (pt)
WO (1)	WO2002055548A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002086101A2 (en)	2001-04-24	2002-10-31	Innogenetics N.V.	Core-glycosylated hcv envelope proteins
AU2003283365A1 (en) *	2002-11-08	2004-06-07	Innogenetics N.V.	HCV vaccine compositions comprising E1 and NS3 peptides
EP1561470A1 (en) *	2003-06-20	2005-08-10	Innogenetics N.V.	HCV vaccines comprising the envelope-1 (E1) protein or the corresponding DNA and at least one antiviral agent
EP2267004A3 (en) *	2003-09-22	2011-04-27	Green Peptide Co., Ltd.	Peptide derived from hepatitis C virus
CN100365124C (zh) *	2005-10-27	2008-01-30	云南大学	一段丙型肝炎病毒特异性cDNA序列的应用
CN115980352A (zh) *	2022-12-30	2023-04-18	宁波博肽生物技术有限公司	一种hcv抗原包被预处理剂、抗原包被方法及检测试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SG71728A1 (en) *	1994-07-29	2000-04-18	Innogenetics Nv	Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use

2002
- 2002-01-11 RU RU2002121632/15A patent/RU2313363C2/ru not_active IP Right Cessation
- 2002-01-11 CZ CZ20032164A patent/CZ20032164A3/cs unknown
- 2002-01-11 BR BR0203518-9A patent/BR0203518A/pt not_active Withdrawn
- 2002-01-11 MX MXPA02008886A patent/MXPA02008886A/es active IP Right Grant
- 2002-01-11 PL PL02363175A patent/PL363175A1/xx unknown
- 2002-01-11 IL IL15103302A patent/IL151033A0/xx unknown
- 2002-01-11 CN CNA028006097A patent/CN1547588A/zh active Pending
- 2002-01-11 EP EP02704649A patent/EP1463753A2/en not_active Withdrawn
- 2002-01-11 TR TR2002/02169T patent/TR200202169T1/xx unknown
- 2002-01-11 KR KR1020027011431A patent/KR20020089371A/ko active IP Right Grant
- 2002-01-11 HU HU0302416A patent/HUP0302416A2/hu unknown
- 2002-01-11 CA CA002400643A patent/CA2400643A1/en not_active Abandoned
- 2002-01-11 WO PCT/EP2002/000219 patent/WO2002055548A2/en active IP Right Grant
- 2002-01-11 AU AU2002238502A patent/AU2002238502B2/en not_active Ceased
- 2002-01-14 AR ARP020100104A patent/AR032240A1/es unknown
- 2002-09-10 NO NO20024325A patent/NO20024325L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
RU2313363C2 (ru)	2007-12-27
MXPA02008886A (es)	2003-04-25
RU2002121632A (ru)	2004-03-20
IL151033A0 (en)	2003-04-10
WO2002055548A8 (en)	2002-10-31
CZ20032164A3 (cs)	2003-10-15
PL363175A1 (en)	2004-11-15
EP1463753A2 (en)	2004-10-06
CN1547588A (zh)	2004-11-17
NO20024325D0 (no)	2002-09-10
HUP0302416A2 (hu)	2003-10-28
AU2002238502B2 (en)	2007-09-06
WO2002055548A2 (en)	2002-07-18
KR20020089371A (ko)	2002-11-29
WO2002055548A3 (en)	2004-08-05
AU2002238502A1 (en)	2002-07-24
BR0203518A (pt)	2002-12-17
AU2002238502B9 (en)	2002-07-24
CA2400643A1 (en)	2002-07-18
TR200202169T1 (tr)	2004-06-21
AR032240A1 (es)	2003-10-29

Publication	Publication Date	Title
LU91326I2 (fr)	2007-05-14	Vaccin papillomavirus humain Ä6,11,16,18Ü(recombinant, adsorbé)
DK1414471T3 (da)	2012-07-16	Terapeutiske midler omfattende pro-apoptotiske proteiner
DE60237823D1 (de)	2010-11-11	Medizinisches behandlungsinstrument
NO20044192L (no)	2004-10-04	17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
DE60312412D1 (de)	2007-04-26	Medizinische Elektroden
DE60223502D1 (de)	2007-12-27	Medizinische schlinge
DE60123990D1 (de)	2006-11-30	Medizinische greifvorrichtung
NO20033753D0 (no)	2003-08-25	System og fremgangsmåte for håndtering av pasientomsorg
DE60118511D1 (de)	2006-05-18	Blutsammelsatz
NO20041186L (no)	2004-05-05	Diagnostiske eller terapeutiske somatostatin- eller bombesinanalogkonjugater og anvendelser derav
DE50209802D1 (de)	2007-05-03	Naht-set für medizinische zwecke
DE50209220D1 (de)	2007-02-22	Medizinische Zange
DE50006890D1 (de)	2004-07-29	Medizinische elektrode
DE60112705D1 (de)	2005-09-22	Blutsammelsatz
DK1411064T3 (da)	2008-03-25	Gangliosid-associerede rekombinante antistoffer og anvendelsen deraf i diagnosen og behandlingen af tumorer
DE60008906D1 (de)	2004-04-15	Medizinische zange
NO20040249L (no)	2004-03-18	Blodgruppeantigenfusjonspolypeptider og fremgangsmater for deres anvendelse
IL162236A0 (en)	2005-11-20	Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use
IS7830A (is)	2005-04-28	Bóluefni gegn lifrarbólgu C veiru (HCV)
EP1425039A4 (en)	2005-02-02	PEPTIDES THAT GIVE AN IMMUNE REACTION WITH THE HUMAN PAPILLOMA VIRUS
NO20033506D0 (no)	2003-08-07	Parasittdrepende preparater og fremgangsmåter for anvendelse
DE50108753D1 (de)	2006-04-06	Medizinisches instrument
DE50200930D1 (de)	2004-10-07	Medizinisches greifinstrument
NO20024325L (no)	2002-11-11	Rensede hepatitt C-viruskappeproteiner for diagnose og terapeutisk anvendelse
IS5777A (is)	2000-12-19	Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess

Legal Events

Date	Code	Title	Description
2009-08-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application